Page not found

Search results

  1. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

    ... has been approved by the FDA for testing as a potential therapeutic for mild to moderate eczema. The peptide, known as AMTX-100, has ... The licensing agreement, facilitated by the  Center for Technology Transfer and Commercialization  and the Office of the Vice Provost ...

    sommers - 10/30/2020 - 12:45pm

  2. Four Vanderbilt technologies earn patent protection

    ...   Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome ...

    sommers - 12/01/2017 - 10:55am

  3. Five Vanderbilt technologies earned patent protection in June

    ... Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic          ...

    batesbs - 10/02/2015 - 10:45am

  4. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... project is now exploiting an antisense microRNA (anti-miR) therapeutic strategy directed to the inhibition of either one or two target ...

    steelmk - 11/15/2016 - 2:29pm

  5. Vanderbilt engineering professor’s company makes successful first-in-human clinical study using novel device for endoscopic surgery

    ... first-in-human clinical study using its innovative technology that radically improves minimally invasive endoscopic surgery. ... innovative designs to enhance safety, particularly in the treatment of biliary disease, which affects about 700,000 patients domestically ...

    sommers - 08/07/2023 - 9:33am

  6. CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year

    05/12/2021 The  Center for Technology Transfer and Commercialization  continued to play a pivotal role ... enables rapid discovery and optimization of broad and potent therapeutic molecules. In July 2020, IDBiologics published results ...

    sommers - 05/26/2021 - 10:39am

  7. Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

    ... partnership, which is facilitated by the  Center for Technology Transfer and Commercialization,  will promote the development of ... “K ATP  channels have a long history of being useful therapeutic targets for treating type 2 diabetes, hypertension and more ...

    sommers - 02/25/2021 - 9:56am

  8. Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

    ... of biochemistry, will continue to lead research and pursue a therapeutic treatment for Charcot-Marie-Tooth disease, a disease that affects ... partnership with Deerfield and grateful to the Center for Technology Transfer and Commercialization team—particularly Alan Bentley and ...

    sommers - 11/17/2020 - 2:53pm

  9. Tech Connect, Vol. 7, Issue 19: GSK Request for Proposals

    ... Technology Spotlight: Targeting ... crucial in angiotensin induced hypertension; and developed a therapeutic strategy that focuses on local or systemic administration of ...

    steelmk - 07/21/2017 - 3:32pm

  10. The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

    ... access to the resulting data for use in drug discovery and therapeutic development.  "We are thrilled to welcome these esteemed ... finding therapeutic targets that are more actionable in the treatment and curing of diseases, while also improving the speed, probability ...

    sommers - 07/20/2023 - 10:17am